CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 2,037.55
+0.85 (0.04%)
At close: Oct 6, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 124.83 billion as of October 7, 2026.
Market Cap
124.83B
Enterprise Value
126.19B
Revenue
14.79B
Global Rank
n/a
Country Rank
n/a
PE Ratio
62.72
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 124.83B, an increase of 41.90%. That is a compound annual growth rate of 53.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 124.83B | 47.38% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 207.20B |
| Caplin Point Laboratories | 203.65B |
| Jubilant Pharmova | 156.49B |
| AstraZeneca Pharma India | 149.58B |
| Viyash Scientific | 101.91B |
| Procter & Gamble Health | 88.01B |
| Morepen Laboratories | 78.77B |
| Bliss GVS Pharma | 71.25B |